National priorities for the assessment of clinical conditions and medical technologies : report of a pilot study

National priorities for the assessment of clinical conditions and medical technologies report of a pilot study

Bibliographic Details
Corporate Authors: Council on Health Care Technology (Institute of Medicine) (-), National Center for Health Services Research and Health Care Technology Assessment (U.S.)
Other Authors: Lara, Marielena (-), Goodman, Clifford
Format: eBook
Language:Inglés
Published: Washington, D.C. : National Academy Press 1990.
Edition:1st ed
Series:IOM publication ; 89-14.
Subjects:
Medical technology > United States.
Clinical medicine > United States.
Technology assessment > United States.
Medical policy > United States.
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820298306719
Table of Contents:
  • National Priorities for the Assessment of Clinical Conditions and Medical Technologies
  • Copyright
  • Acknowledgments
  • Foreword
  • Contents
  • Summary
  • ASSESSING MEDICAL PRACTICE
  • A NATIONAL APPROACH
  • PRIORITY-SETTING CRITERIA
  • TWENTY ASSESSMENT PRIORITIES
  • USING THE PRIORITIES
  • ACCOMMODATING CLINICAL CONDITIONS AND TECHNOLOGIES
  • NEXT STEPS
  • 1 Introduction
  • 2 A Pilot Process for Setting National Assessment Priorities
  • ELEMENTS OF A NATIONAL APPROACH
  • NATIONALLY APPLICABLE PRIORITY-SETTING CRITERIA
  • Primary Criteria
  • Potential (for an Assessment) to Improve Individual Patient Outcome
  • Potential to Affect a Large Patient Population
  • Potential to Reduce Unit or Aggregate Cost
  • Potential to Reduce Unexplained Variations in Medical Practice
  • Secondary Criteria
  • Potential to Address Social and Ethical Implications
  • Potential to Advance Medical Knowledge
  • Potential to Affect Policy Decisions
  • Potential to Enhance the National Capacity for Assessment
  • Potential to Be Readily Conducted
  • A CONCEPTUAL FRAMEWORK FOR PRIORITIES
  • The Clinical Condition Approach
  • The Technology Approach
  • Integrating the Clinical Condition and Technology Approaches
  • METHOD OF THIS PILOT STUDY
  • Overview
  • Round I of the Modified Delphi Process
  • Round II of the Modified Delphi Process
  • The Priority-Setting Group's Meeting
  • Activities Following the Priority-Setting Meeting
  • 3 Twenty Priority Assessment Areas
  • CLINICAL CONDITIONS
  • Breast Cancer
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Advance Medical Knowledge
  • Affect Policy Decisions
  • Cataracts
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost.
  • Reduce Unexplained Variations in Medical Practice
  • Affect Policy Decisions
  • Enhance the national capacity for technology assessment
  • Chronic Obstructive Pulmonary Disease
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Address Social and Ethical Implications
  • Enhance the National Capacity for Technology Assessment
  • Coronary Artery Disease
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Advance Medical Knowledge
  • Gallbladder Disease
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Advance Medical Knowledge
  • Gastrointestinal Bleeding
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Affect Policy Decisions
  • Human Immunodeficiency Virus Infection
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Advance Medical Knowledge
  • Address Social and Ethical Implications
  • Affect Policy Decisions
  • Enhance the National Capacity for Assessment
  • Joint Disease and Injury
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Advance Medical Knowledge
  • Low Back Pain
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Advance Medical Knowledge.
  • Address Social and Ethical Implications
  • Osteoporosis
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Advance Medical Knowledge
  • Affect Policy Decisions
  • Pregnancy
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce unexplained variations in medical practice
  • Advance Medical Knowledge
  • Affect Policy Decisions
  • Prostatism
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Advance medical knowledge
  • Enhance the National Capacity for Technology Assessment
  • Psychiatric Disorders
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Advance Medical Knowledge
  • Affect Policy Decisions
  • Substance Abuse
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Address Social and Ethical Implications
  • Advance Medical Knowledge
  • Affect Policy Decisions
  • TECHNOLOGIES
  • Diagnostic Imaging Technologies
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Address Social and Ethical Implications
  • Advance Medical Knowledge
  • Affect Policy Decisions
  • Diagnostic Laboratory Testing
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Advance Medical Knowledge
  • Affect Policy Decisions
  • Erythropoietin
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost.
  • Affect Policy Decisions
  • Implantable Devices
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Intensive Care Units
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Reduce Unexplained Variations in Medical Practice
  • Address Social and Ethical Implications
  • Advance Medical Knowledge
  • Affect Policy Decisions
  • Organ Transplantation and Replacement
  • Improve Individual Patient Outcome
  • Affect a Large Patient Population
  • Reduce Unit or Aggregate Cost
  • Address Social and Ethical Implications
  • Advance Medical Knowledge
  • Affect Policy Decisions
  • 4 Next Steps
  • 5 Conclusions and Recommendations
  • Appendixes
  • A Clinical Conditions and Medical Technologies Considered by the Priority-Setting Group
  • B Comparison of Priority-Setting Criteria
  • C Organizations Providing Background Information
  • American College of Physicians (ACP)
  • American Hospital Association (AHA)
  • American Medical Association (AMA)
  • Blue Cross and Blue Shield Association (BCBS)
  • Ecri
  • Hewlett-Packard Company
  • Institute for Health Policy Analysis (IHPA), Georgetown University
  • Institute of Medicine Committee on the Effectiveness Initiative of the Health Care Financing Adminis ...
  • Metropolitan Life Insurance Company
  • Office of Health Technology Assessment (OHTA), National Center for Health Services Research
  • Office of Medical Applications of Research (OMAR), National Institutes of Health (NIH)
  • Office of Technology Assessment (OTA), U.S. Congress
  • Pfizer, Inc.
  • Prospective Payment Assessment Commission (ProPAC)
  • Bibliography
  • Glossary.

Similar Items